Difference between revisions of "Normative:Variant of SARS-CoV-2"
(formatting) |
|||
| Line 10: | Line 10: | ||
===Definition=== | ===Definition=== | ||
These | These SARS-CoV-2 variants are designated as variants of concern (VoC) if they are associated with select characteristics, such as increase in transmissibility or virulence, decrease in effectiveness of vaccines and/or therapeutics, or interference with diagnostic test targets. | ||
<small>Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf</small> | <small>Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf</small> | ||
=== Encyclopaedic information === | === Encyclopaedic information === | ||
Emerging data regarding the prevalence and clinical significance of | Emerging data regarding the prevalence and clinical significance of SARS-CoV-2 variants, and the efficacy of monoclonal antibodies against variants, may inform the choice of specific anti-SARS-CoV-2 monoclonal antibody therapy in the future. | ||
<small>Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf</small> | <small>Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf</small> | ||
| Line 38: | Line 38: | ||
===Note=== | ===Note=== | ||
SARS-CoV-2 variant is used more often than variant of SARS-CoV-2. | "SARS-CoV-2 variant" is used more often than variant of "SARS-CoV-2". | ||
Latest revision as of 21:32, 7 March 2022
Normative
Variants and synonyms
- SARS-CoV-2 variant
Definition
These SARS-CoV-2 variants are designated as variants of concern (VoC) if they are associated with select characteristics, such as increase in transmissibility or virulence, decrease in effectiveness of vaccines and/or therapeutics, or interference with diagnostic test targets. Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
Encyclopaedic information
Emerging data regarding the prevalence and clinical significance of SARS-CoV-2 variants, and the efficacy of monoclonal antibodies against variants, may inform the choice of specific anti-SARS-CoV-2 monoclonal antibody therapy in the future. Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
Examples
Member States should also strongly discourage all non-essential travel to and from areas with a high prevalence of SARS-CoV-2 variants of concern or interest and to and from areas with an unknown prevalence due to insufficient sequencing volume.
Source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021H0961
Collocations
- new SARS-CoV-2 variant
- to track SARS-CoV-2 variant
- to study SARS-CoV-2 variant
Keyness
- variant of SARS-CoV-2: >1000
- SARS-CoV-2 variant: >1000
Note
"SARS-CoV-2 variant" is used more often than variant of "SARS-CoV-2".